We report the efficacy of fenofibrate in a patient with CPT2 deficiency, in whom beta-oxidation was improved but an episode of rhabdomyolysis nevertheless occurred. The gene discussed is CPT2; the disease is hyperinsulinemic hypoglycemia, familial, 4.